Morning Overview on MSN
A single molecule just shut down the gene behind the deadliest brain cancer in mice — and it did it without one harmful side effect
Glioblastoma kills roughly 10,000 Americans every year. Patients diagnosed with a recurrence after standard chemotherapy face ...
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, and Hemispherian AS, a clinical-stage ...
Temozolomide is an alkylating cytostatic drug that finds increasing application in the treatment of melanoma, anaplastic astrocytoma and glioblastoma multiforme. The compound is a prodrug that ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Temozolomide with radiation therapy improved 5- and ...
A new research paper was published in Volume 13 of Oncoscience on April 2, 2026, titled "Selective blood–brain barrier ...
Both radiation and temozolomide, a generic chemotherapy treatment in pill form, have meaningful single-modality anti-tumor activity against slow-growing, low-grade gliomas. The randomized phase 3 ...
Methotrexate (MTX)-based chemotherapy extends survival in patients with primary brain lymphomas, but it is not clear whether multiagent chemotherapy is superior to MTX alone. Treatment options for ...
Credit: Getty Images. Temozolomide is the second drug to receive a labeling update under Project Renewal. The Food and Drug Administration (FDA) has approved updated labeling for temozolomide (Temodar ...
Learn the correct pronunciation of the Temozolomide, understand it's uses, recommended dosages, its indications, how to take, when to take, when not to take, side effects, special precautions, ...
LONDON, 6 February, 2009 -- Sales of Temozolomide*, an anti-cancer drug developed by Cancer Research UK scientists, have reached $1 billion**. The charity receives a percentage royalty on these sales, ...
A photo of co-authors from the Department of Neurosurgery, Niigata University, including Dr. Takuya Okada (middle) and Dr. Manabu Natsumeda (right of Dr. Okada). A team led by Dr. Manabu Natsumeda ...
Glioblastoma, the most common primary brain tumor in adults, is usually rapidly fatal. The current standard of care for newly diagnosed glioblastoma is surgical resection to the extent feasible, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results